For more than 20 years, Prime Therapeutics/Magellan Rx Management (Prime/Magellan Rx) has helped Medicaid programs manage traditional drugs with its preferred drug list (PDL) and other utilization management strategies. With the advent of novel cell and gene therapies, and a higher use of physician administered drugs (PADs), Medicaid programs must evolve their drug management model with modern technology infrastructure. At the annual Medicaid Enterprise Systems Conference (MESC) in Louisville, Kentucky, from August 12–15, 2024, Prime/Magellan Rx experts will share innovative solutions for the unique needs of state Medicaid programs and their members. This conference offers opportunities for “state, federal and private sector individuals to exchange ideas related to Medicaid systems and health policy affected by those systems,” according to the MESC website.

Event:

Medicaid Enterprise Systems Conference (MESC)

Educational Session:

“Managing Medicaid pharmacy spend and maximizing use of technology to support state efforts”

Date/time:

Wednesday, Aug. 14 | 3– 4 p.m. CT

Presenters:

• Tina Hawkins, PharmD, vice president of account management, Prime/Magellan Rx
• Dave Rice, vice president of information technology, Prime/Magellan Rx
• Gabe Schoenlein, lead business analyst, Prime/Magellan Rx
• Amber Small, senior director of pharmacy pricing and value-based solutions, Prime/Magellan Rx
• Jami Snyder, owner, JSN Strategies LLC
• Doug Brown, senior vice president of value and access, Coeus Consulting Group

Learn more about MESC conference 2024